Evidence map›Paper›PMID 28848808›Full record

ReviewChronic obstructive pulmonary diseases (Miami, Fla.)2014

Clinical Characteristics of Patients With Biomass Smoke-Associated COPD and Chronic Bronchitis, 2004-2014.

Rogelio Pérez-Padilla, Alejandra Ramirez-Venegas, Raul Sansores-Martinez

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Chronic obstructive pulmonary diseases (Miami, Fla.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03984188 (Effectiveness of Low-Dose Theophylline for the Management of Biomass-Associated COPD), which is not on this map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03984188 phase3completednot on this mapstarted 2021, after this paper: background citation

Effectiveness of Low-Dose Theophylline for the Management of Biomass-Associated COPD

TypeinterventionalSponsorUniversity of MiamiRan2021 to 2023Enrolled100ConditionsCOPD, COPD Exacerbation, COPD Exacerbation Acute, Pollution Related Respiratory DisorderArmsTheophylline ER, Placebo oral tablet, Standard of Care Treatment
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Bronchodilators for hyperinflation in COPD associated with biomass smoke: clinical trial.International journal of chronic obstructive pulmonary disease · 2019
    Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Sputum Biomarkers in Wood and Tobacco Smoke Etiotypes of Chronic Obstructive Pulmonary Disease.International journal of chronic obstructive pulmonary disease · 2024
    Article
  12. Article
  13. Role of mucociliary clearance system in respiratory diseases.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2023
    Article
  14. Article
  15. COPD Risk Factor Profiles in General Population and Referred Patients: Potential Etiotypes.International journal of chronic obstructive pulmonary disease · 2023
    Observational
  16. Article
  17. Review
  18. Household air pollution and COPD: cause and effect or confounding by other aspects of poverty?The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2022
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Rogelio Pérez-PadillaSleep Clinic, National Institute of Respiratory Diseases, Mexico City.
Alejandra Ramirez-VenegasCOPD and Smoking Clinic, National Institute of Respiratory Diseases, Mexico City.
Raul Sansores-MartinezCOPD and Smoking Clinic, National Institute of Respiratory Diseases, Mexico City.
National Institute of Cardiovascular Diseases · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Individuals with chronic obstructive pulmonary disease (COPD) associated with biomass smoke inhalation tend to be women born in rural areas with lifelong exposure to open fires while cooking, but can also include persons with prenatal and childhood exposure. Compared with individuals with COPD due to tobacco smoking, individuals exposed to biomass smoke uncommonly have severe airflow obstruction, low diffusing capacity of the lung for carbon monoxide (DLCO) or emphysema in high-resolution computed tomography (HRCT) but cough, phlegm and airway thickening and air trapping are very common. Autopsies of patients with COPD from biomass smoke exposure show increased pulmonary artery small vessel intimal thickening which may explain pulmonary hypertension, in addition to emphysema and airway disease. Research on similarities and differences in lung damage produced by exposure to biomass fuel smoke while cooking vs. smoking tobacco may provide new insights on COPD. As a public health problem, COPD caused by inhalation of smoke from burning solid fuel is as relevant as COPD caused by smoking tobacco but mainly affects women and children from disadvantaged areas and countries and requires an organized effort for its control. Improved vented biomass stoves are currently the most feasible intervention, but even more efficient stoves are necessary to reduce the biomass smoke exposure and reduce incidence of COPD among this population.

Indexed as

biomasscopdimproved biomass stoveindoor pollutiontobacco smoking

Identifiers

PMID28848808
PMCPMC5559138
OpenAlexW2320764295

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.